Nuvalent, Inc. (NUVL) Stock price, Description, News & Info

#Thinksabio latest news

Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium